Imiquimod: In Vivo and In Vitro Characteristics and Toxicology
- 12 March 1997
- book chapter
- Published by Taylor & Francis
- p. 425-448
- https://doi.org/10.1201/9781420001969-34
Abstract
Mice Imiquimod (R-837, S-26308) (Figure 1) is a potent inducer of cytokines in a number of species including mice, rats, guinea pigs, monkeys, and humans (1-7). In mice, studies have demonstrated induction of interferon (IFN) in the serum as early as 1 hour after treatment. Concentrations of IFN generally peak 2 hours after dosing and at doses lower than 30 mg/kg return to background by 4 to 6 hours after administration. At doses higher than 30 mg/kg, peak concentrations of IFN are not any higher than those seen at the 30 mg/kg dose; however, IFN concentrations remain elevated for an extended time. Imiquimod not only induces IFN but also causes increases in tumor necrosis factor (TNF)-a and interleukin (IL)-6.Keywords
This publication has 0 references indexed in Scilit: